According to SMS Pharmaceuticals latest financial reports the cash on hand of SMSPHARMA is $1.68M, an decrease of -70.02% to 2022. At the end of 2022 company had $5.59M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $1.68M | -70.02% |
2022 | $5.59M | 14.84% |
2021 | $4.87M | 328.23% |
2020 | $1.14M | -35.50% |
2019 | $1.76M | - |